Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Operating Income (2024 - 2025)

Historic Operating Income for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to -$23.5 million.

  • Pyxis Oncology's Operating Income rose 123.35% to -$23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$106.2 million, marking a year-over-year change of. This contributed to the annual value of -$89.5 million for FY2024, which is 883.74% down from last year.
  • As of Q3 2025, Pyxis Oncology's Operating Income stood at -$23.5 million, which was up 123.35% from -$19.8 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Operating Income registered a high of -$5.6 million during Q1 2024, and its lowest value of -$40.1 million during Q4 2024.